Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-1-6
|
pubmed:abstractText |
Myrmecia warts induced by human papillomavirus type 1 (HPV1) are characterized by abundant eosinophilic inclusions associated with HPV1 E4 gene products. The major HPV1 E4 proteins are a 17-kilodalton (kDa) E1-E4 fusion protein and a 16-kDa species lacking the five E1 amino acids and a few E4 residues. To study the contribution of E4 proteins to the formation of myrmecia inclusions, we used a previously designed transient expression system in the rabbit VX2-R keratinocyte line. We find that the E1-E4 and an E4 protein without the E1 residues (E4-3200) form eosinophilic inclusions. Ultrastructural and immunoelectron microscopic studies show that the electron-dense, keratohyalin-like myrmecia inclusions are recognized by anti-E4 antibodies. They are associated with tonofilament bundles at their periphery in the cytoplasm or free of filaments in the nucleus. The E1-E4 inclusions formed in vitro are also homogeneously electron dense, and are usually associated with tonofilaments at their periphery in the cytoplasm and free of filaments in the nucleus. The E4-3200 inclusions are exclusively cytoplasmic and heterogeneously electron dense, with a fibrillar structure made of entangled 10-nm filaments. The expression of either protein in VX2-R cells does not result in the collapse of the cytokeratin network, as shown by immunofluorescence double-labeling experiments. This is in contrast to data reported for the HPV16 E1-E4 protein. Our findings indicate that the E1-E4 protein by itself accounts for the formation of myrmecia inclusions, and suggest that the five N-terminal E1 amino acids play a major role in the interaction of E4 proteins with intermediate filaments.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-202X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
843-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7504028-Adenovirus E4 Proteins,
pubmed-meshheading:7504028-Amino Acid Sequence,
pubmed-meshheading:7504028-Animals,
pubmed-meshheading:7504028-Cell Line,
pubmed-meshheading:7504028-Cytopathogenic Effect, Viral,
pubmed-meshheading:7504028-Cytoplasmic Granules,
pubmed-meshheading:7504028-Fluorescent Antibody Technique,
pubmed-meshheading:7504028-Humans,
pubmed-meshheading:7504028-Inclusion Bodies,
pubmed-meshheading:7504028-Keratinocytes,
pubmed-meshheading:7504028-Keratins,
pubmed-meshheading:7504028-Microscopy, Immunoelectron,
pubmed-meshheading:7504028-Molecular Sequence Data,
pubmed-meshheading:7504028-Papillomaviridae,
pubmed-meshheading:7504028-Rabbits,
pubmed-meshheading:7504028-Tumor Cells, Cultured
|
pubmed:year |
1993
|
pubmed:articleTitle |
Cytopathic effect in human papillomavirus type 1-induced inclusion warts: in vitro analysis of the contribution of two forms of the viral E4 protein.
|
pubmed:affiliation |
Unité INSERM 190, Institut Pasteur, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|